27 research outputs found
Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma
Background: The molecular mechanisms involved in the development and progression of clear cell renal cell carcinomas (ccRCCs) are poorly understood. The objective of this study was to analyze the expression of dual-specificity phosphatase 9 (DUSP-9) and determine its clinical significance in human ccRCCs. Methods: The expression of DUSP-9 mRNA was determined in 46 paired samples of ccRCCs and adjacent normal tissues by using real-time qPCR. The expression of the DUSP-9 was determined in 211 samples of ccRCCs and 107 paired samples of adjacent normal tissues by immunohistochemical analysis. Statistical analysis was performed to define the relationship between the expression of DUSP-9 and the clinical features of ccRCC. Results: The mRNA level of DUSP-9, which was determined by real-time RT-PCR, was found to be significantly lower in tumorous tissues than in the adjacent non-tumorous tissues (p < 0.001). An immunohistochemical analysis of 107 paired tissue specimens showed that the DUSP-9 expression was lower in tumorous tissues than in the adjacent non-tumorous tissues (p < 0.001). Moreover, there was a significant correlation between the DUSP-9 expression in ccRCCs and gender (p = 0.031), tumor size (p = 0.001), pathologic stage (p = 0.001), Fuhrman grade (p = 0.002), T stage (p = 0.001), N classification (p = 0.012), metastasis (p = 0.005), and recurrence (p < 0.001). Patients with lower DUSP-9 expression had shorter overall survival time than those with higher DUSP-9 expression (p < 0.001). Multivariate analysis indicated that low expression of the DUSP-9 was an independent predictor for poor survival of ccRCC patients. Conclusion: To our knowledge, this is the first study that determines the relationship between DUSP-9 expression and prognosis in ccRCC. We found that decreased expression of DUSP-9 is associated with poor prognosis in ccRCC. DUSP-9 may represent a novel and useful prognostic marker for ccRCC
C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation
Recommended from our members
KULL: LLNL's ASCI Inertial Confinement Fusion Simulation Code
KULL is a three dimensional, time dependent radiation hydrodynamics simulation code under development at Lawrence Livermore National Laboratory. A part of the U.S. Department of Energy's Accelerated Strategic Computing Initiative (ASCI), KULL's purpose is to simulate the physical processes in Inertial Confinement Fusion (ICF) targets. The National Ignition Facility, where ICF experiments will be conducted, and ASCI are part of the experimental and computational components of DOE's Stockpile Stewardship Program. This paper provides an overview of ASCI and describes KULL, its hydrodynamic simulation capability and its three methods of simulating radiative transfer. Particular emphasis is given to the parallelization techniques essential to obtain the performance required of the Stockpile Stewardship Program and to exploit the massively parallel processor machines that ASCI is procuring